肝病对肝脏微环境的影响以及对免疫疗法的影响
Zachary J Brown1, Samantha M Ruff2, Timothy M Pawlik2
1Department of Surgery, New York University Long Island School of Medicine, Mineola, NY, United States.
Frontiers in pharmacology
|August 23, 2023
概括
肝细胞癌 (HCC) 的进展与肝脏免疫微环境有关. 了解这些变化是克服治疗耐药性和开发新的HCC治疗方法的关键.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 肝细胞癌 (HCC) 是癌症死亡的首要原因,通常是由慢性肝病引起的.
- 瘤免疫微环境显著影响HCC的发展,进展和治疗反应.
- 慢性肝病,如病毒性肝炎和NAFLD改变免疫格局,影响HCC.
研究的目的:
- 审查免疫微环境在HCC中的作用.
- 检查肝脏疾病如何影响HCC的免疫微环境.
- 探索与免疫变化和未来治疗策略相关的治疗耐药性.
主要方法:
- 文献综述侧重于HCC,肝病和免疫微环境.
- 对肝脏瘤背景下的免疫细胞相互作用现有研究的分析.
- 对治疗耐药性机制的研究结果的综合.
主要成果:
- 免疫微环境对于HCC的发展和对治疗的反应至关重要.
- 肝病显著改变免疫微环境,影响HCC.
- 免疫微环境的改变与对当前疗法的耐药性有关.
结论:
- 了解肝病,免疫微环境和HCC之间的相互作用至关重要.
- 准免疫微环境有望克服HCC的治疗耐药性.
- 未来的HCC疗法应该考虑免疫调节以改善结果.
关键词:
肝细胞癌 (HCC) 是一种肝细胞癌.酒精诱导的肝脏疾病肝硬化是肝硬化的一种疾病.免疫检查抑制剂 (ICI) 免疫检查抑制剂免疫的微型环境肝脏疾病 肝脏疾病非酒精性脂肪肝疾病非酒精性脂肪肝疾病病毒性肝炎是一种病毒性肝炎.更多相关视频
11:44Long Term Intravital Multiphoton Microscopy Imaging of Immune Cells in Healthy and Diseased Liver Using CXCR6.Gfp Reporter Mice
Published on: March 24, 2015
12.0K
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.3K
相关概念视频
Liver Regeneration
3.3K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.3K
Diseases of the Liver and Gallbladder
629
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
629
Liver Physiology
632
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
632
Hepatic Drug Excretion: Influencing Factors
152
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
152
